Antinociceptive effect of cannabinoid agonist WIN 55,212-2 in rats with a spinal cord injury

被引：35

作者：

Hama, Aldric ^{[1
]}

Sagen, Jacqueline ^{[1
]}

机构：

[1] Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Miami, FL 33136 USA

来源：

EXPERIMENTAL NEUROLOGY | 2007年 / 204卷 / 01期

关键词：

AM; 251; 630; allodynia; chronic pain; CB1; receptor; neuropathic pain;

D O I：

10.1016/j.expneurol.2006.09.002

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

Spinal cord injury (SCI) pain exhibits many symptoms associated with peripheral neuropathic pain, including increased tactile hypersensitivity. One novel approach to ameliorate SCI pain is the use of cannabinoid (CB) ligands. The current study evaluated the efficacy of the nonselective CB receptor agonist WIN 55,212-2 on tactile hypersensitivity in rats following a brief compression to the thoracic spinal cord. The withdrawal thresholds of the hind paws following SCI were significantly decreased, indicating tactile hypersensitivity. Systemic injection of WIN 55,212-2 increased withdrawal thresholds in a dose-dependent manner. Pretreatment with the CB1 receptor subtype-selective antagonist AM 251 completely abolished the antinociceptive effect of WIN 55,212-2 whereas pretreatment with the CB2 receptor subtype-selective antagonist AM 630 did not alter the antinociceptive effect of WIN 55,212-2. These data indicate that a CB1-selective agonist may be novel therapeutic treatment for clinical SCI pain. (c) 2006 Elsevier Inc. All rights reserved.

引用

页码：454 / 457

页数：4

共 27 条

[1] Are oral cannabinoids safe and effective in refractory neuropathic pain? [J].

Attal, N ;

Brasseur, L ;

Guirimand, D ;

Clermond-Griamien, S ;

Atlami, S ;

Bouhassira, D .

EUROPEAN JOURNAL OF PAIN, 2004, 8 (02) :173-177

[2] A SENSITIVE AND RELIABLE LOCOMOTOR RATING-SCALE FOR OPEN-FIELD TESTING IN RATS [J].

BASSO, DM ;

BEATTIE, MS ;

BRESNAHAN, JC .

JOURNAL OF NEUROTRAUMA, 1995, 12 (01) :1-21

[3] The synthetic cannabinoid WIN55,212-2 attenuates hyperalgesia and allodynia in a rat model of neuropathic pain [J].

Bridges, D ;

Ahmad, K ;

Rice, ASC .

BRITISH JOURNAL OF PHARMACOLOGY, 2001, 133 (04) :586-594

[4] Chronic pain after clip-compression injury of the rat spinal cord [J].

Bruce, JC ;

Oatway, MA ;

Weaver, LC .

EXPERIMENTAL NEUROLOGY, 2002, 178 (01) :33-48

[5] Are cannabinoids an effective and safe treatment option in the management of pain?: A qualitative systematic review [J].

Campbell, FA ;

Tramèr, MR ;

Carroll, D ;

Reynolds, DJ ;

Moore, RA ;

McQuay, HJ .

BMJ-BRITISH MEDICAL JOURNAL, 2001, 323 (7303) :13-16

[6] Treatments for chronic pain in persons with spinal cord injury: A survey study [J].

Cardenas, Diana D. ;

Jensen, Mark P. .

JOURNAL OF SPINAL CORD MEDICINE, 2006, 29 (02) :109-117

[7] QUANTITATIVE ASSESSMENT OF TACTILE ALLODYNIA IN THE RAT PAW [J].

CHAPLAN, SR ;

BACH, FW ;

POGREL, JW ;

CHUNG, JM ;

YAKSH, TL .

JOURNAL OF NEUROSCIENCE METHODS, 1994, 53 (01) :55-63

[8] Cannabinoid CB1 receptor expression in rat spinal cord [J].

Farquhar-Smith, WP ;

Egertová, M ;

Bradbury, EJ ;

McMahon, SB ;

Rice, ASC ;

Elphick, MR .

MOLECULAR AND CELLULAR NEUROSCIENCE, 2000, 15 (06) :510-521

[9] MRI in chronic spinal cord injury patients with and without central pain [J].

Finnerup, NB ;

Gyldensted, C ;

Nielsen, E ;

Kristensen, AD ;

Bach, FW ;

Jensen, TS .

NEUROLOGY, 2003, 61 (11) :1569-1575

[10] The role of central and peripheral Cannabinoid1 receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic pain [J].

Fox, A ;

Kesingland, A ;

Gentry, C ;

McNair, K ;

Patel, S ;

Urban, L ;

James, I .

PAIN, 2001, 92 (1-2) :91-100

← 1 2 3 →